AstraZeneca Plc
(NASDAQ) AZN
AstraZeneca Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$58.74B
Net Income (TTM)
$10.22B
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AZN News
AZN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AstraZeneca Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
96,100
CEO
Pascal Soriot, MBA, DVM
Website
www.astrazeneca.comHeadquarters
Cambridge, CB2 0AA, GB
AZN Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
23%
Net Income Margin
17%
Return on Equity
23%
Return on Capital
17%
Return on Assets
9%
Earnings Yield
N/A
Dividend Yield
1.65%
Payout Ratio
47.94%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$48.11B
Operating Income
$13.74B
EBITDA
$19.83B
Operating Cash Flow
$14.57B
Capital Expenditure
$2.81B
Free Cash Flow
$11.77B
Cash & ST Invst.
$5.74B
Total Debt
$29.70B
AstraZeneca Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.50B
+4.1%
Gross Profit
$12.38B
+1.8%
Gross Margin
79.89%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
94,300
N/A
Net Income
$2.33B
+55.1%
EBITDA
$4.61B
+64.2%
Quarterly Fundamentals
Net Cash
$23.96B
+2.0%
Accounts Receivable
$15.18B
+17.0%
Inventory
$6.56B
+24.0%
Long Term Debt
$26.14B
-5.4%
Short Term Debt
$3.57B
+43.0%
Return on Assets
9.09%
N/A
Return on Invested Capital
16.60%
N/A
Free Cash Flow
$1.38B
-29.5%
Operating Cash Flow
$2.43B
-16.4%